Summary

Persistence Market Research has recently unveiled a comprehensive report on the global market for flu vaccines. This report provides an in-depth evaluation of essential market dynamics, including drivers, trends, opportunities, and challenges, offering detailed insights into the market structure.

Key Insights:

• Flu Vaccines Market Size (2024E): USD 5.75 Billion
• Projected Market Value (2033F): USD 10.2 Billion
• Global Market Growth Rate (CAGR 2024 to 2033): 6.6%

Flu Vaccines Market - Report Scope:

Flu vaccines are critical in preventing seasonal influenza and mitigating the effects of flu outbreaks. These vaccines are vital for public health, providing protection against various strains of influenza viruses. The flu vaccines market serves healthcare providers, hospitals, clinics, and public health organizations, offering a range of vaccine types, including trivalent and quadrivalent formulations, as well as newer vaccines targeting multiple flu strains. Market expansion is driven by growing awareness of influenza prevention, increased healthcare spending, and advancements in vaccine technology, which enhance both efficacy and safety.

Market Growth Drivers:

The global flu vaccines market is driven by several key factors, including heightened awareness about the importance of vaccination in preventing seasonal flu and reducing healthcare burdens. The rising incidence of influenza-related complications, particularly among vulnerable groups such as the elderly and young children, further accelerates market growth. Technological advancements, including the development of high-dose and adjuvanted vaccines, offer enhanced protection and spur market growth. Additionally, the widespread adoption of vaccination programs by governments and health organizations globally is creating significant demand for flu vaccines.

Market Restraints:

Despite positive growth prospects, the flu vaccines market faces challenges related to vaccine hesitancy, high production costs, and regulatory hurdles. Vaccine hesitancy, driven by concerns over vaccine safety and efficacy, can negatively impact vaccination rates and market growth. High production costs and complex manufacturing processes pose challenges for vaccine accessibility and affordability, especially in low- and middle-income countries. Additionally, stringent regulatory requirements for vaccine approval and distribution create operational complexities for manufacturers, affecting market dynamics.

Market Opportunities:

The flu vaccines market offers substantial growth opportunities driven by technological innovations, demographic trends, and evolving healthcare delivery models. The development of new vaccine formulations, including those targeting multiple strains and offering extended protection, enhances market potential. Additionally, the growing application of flu vaccines in preventive health strategies, such as integrated vaccination programs and collaborations with public health initiatives, broadens the market scope. Strategic investments in research and development, coupled with partnerships with healthcare providers and governmental agencies, are crucial for capitalizing on emerging opportunities and sustaining market growth.

Key Questions Answered in the Report:

• What are the primary factors driving the growth of the global flu vaccines market?
• Which vaccine types and formulations are contributing to the increased adoption of flu vaccines across different regions?
• How are technological advancements transforming the competitive landscape of the flu vaccines market?
• Who are the key players in the flu vaccines market, and what strategies are they using to maintain market relevance?
• What are the emerging trends and future prospects in the global flu vaccines market?

Competitive Intelligence and Business Strategy:

Leading companies in the global flu vaccines market, such as GlaxoSmithKline plc, Pfizer Inc., Sanofi Pasteur, and AstraZeneca, are focusing on innovation, product differentiation, and strategic partnerships to maintain a competitive edge. These firms invest in R&D to develop advanced vaccine formulations, including high-dose and adjuvanted vaccines, catering to diverse patient needs and public health requirements. Collaborations with government health agencies, public health organizations, and research institutions facilitate market access and promote technology adoption. Furthermore, an emphasis on clinical research, evidence-based practices, and public education bolsters market growth and vaccine uptake in the evolving flu vaccines landscape.

Key Companies Profiled:

• Sanofi Pasteur Inc.
• AstraZeneca
• Csl Ltd.
• Abbott
• GlaxoSmithKline Plc.
• Serum Institute Of India Pvt.Ltd

Key Segments Covered in Flu Vaccines Industry Research

Product:
• Trivalent Flu Vaccine
• Quadrivalent Flu Vaccine

Dosage Form:
• Intramuscular Injection
• Nasal Spray
• Intradermal Shot

Distribution Channel:
• Institutional Sales
• Retail Sales

Region:
• North America
• Latin America
• Europe
• South Asia
• East Asia
• Oceania
• Middle East and Africa

ページTOPに戻る

Table of Contents

1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
2.3. Inclusions and Exclusions
3. Key Market Trends
3.1. Key Trends Impacting the Market
3.2. Product Innovation / Development Trends
4. Value Added Insights
4.1. Production Strategy
4.2. Volume Consumption
4.3. Production Cost
4.4. Pipeline Assessment
4.5. Patent Analysis
4.6. PESTEL Analysis
4.7. Porter’s Analysis
5. Market Background
5.1. Macro-Economic Factors
5.1.1. Global GDP Growth Outlook
5.1.2. Global Healthcare Outlook
5.1.3. Growing government support and focus for the development of the vaccines
5.2. Forecast Factors - Relevance & Impact
5.2.1. Development of Vaccine Products
5.2.2. Regulatory Imposition
5.2.3. Increasing Expenditure on Research and Development
5.2.4. Increasing Prevalence of Seasonal Flu
5.2.5. Increased Vaccination Rates
5.2.6. High Rate of Manufacturing
5.2.7. Strategic Mergers and Acquisitions Among Local Manufacturers
5.3. Market Dynamics
5.3.1. Drivers
5.3.2. Restraints
5.3.3. Opportunity Analysis
6. COVID-19 Crisis Analysis
6.1. COVID-19 and Impact Analysis
6.2. 2024 Market Scenario
7. Global Market Volume (Units) Analysis 2019-2023 and Forecast, 2024-2033
7.1. Historical Market Volume (Units) Analysis, 2019-2023
7.2. Current and Future Market Volume (Units) Projections, 2024-2033
7.2.1. Y-o-Y Growth Trend Analysis
8. Global Market- Pricing Analysis
8.1. Regional Pricing Analysis By Product
8.2. Price Break up
8.2.1. Manufacturer Level
8.2.2. Distributor Level
8.3. Global Average Pricing Analysis Benchmark
8.3.1. Pricing Assumptions
9. Global Market Demand (in Value or Size in US$ Bn) Analysis 2019-2023 and Forecast, 2024-2033
9.1. Historical Market Value (US$ Bn) Analysis, 2019-2023
9.2. Current and Future Market Value (US$ Bn) Projections, 2024-2033
9.2.1. Y-o-Y Growth Trend Analysis
9.2.2. Absolute $ Opportunity Analysis
10. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Product
10.1. Introduction / Key Findings
10.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Product, 2019-2023
10.3. Current and Future Market Size (US$ Bn) and Volume (Units) Analysis and Forecast By Product, 2024-2033
10.3.1. Trivalent Flu Vaccine
10.3.2. Quadrivalent Flu Vaccine
10.4. Market Attractiveness Analysis By Product
11. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Dosage Form
11.1. Introduction / Key Findings
11.2. Historical Market Size (US$ Bn) Analysis, By Dosage Form, 2019-2023
11.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Dosage Form, 2024-2033
11.3.1. Intramuscular Injection
11.3.2. Nasal Spray
11.3.3. Intradermal Shot
11.4. Market Attractiveness Analysis By Dosage Form
12. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Distribution Channels
12.1. Introduction / Key Findings
12.2. Historical Market Size (US$ Bn) Analysis, By Distribution Channels, 2019-2023
12.3. Current and Future Market Size (US$ Bn) Analysis and Forecast By Distribution Channels, 2024-2033
12.3.1. Institutional Sales
12.3.1.1. Hospitals
12.3.1.2. Community Clinics
12.3.1.3. Public Health Agencies
12.3.1.4. Workplace Purchasing
12.3.2. Retail Sales
12.3.2.1. Retail Pharmacies
12.3.2.2. Mail Order Pharmacies
12.4. Market Attractiveness Analysis By Distribution Channels
13. Global Market Analysis 2019-2023 and Forecast 2024-2033, By Region
13.1. Introduction
13.2. Historical Market Size (US$ Bn) and Volume (Units) Analysis By Region, 2019-2023
13.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
13.3.1. North America
13.3.2. Latin America
13.3.3. Europe
13.3.4. East Asia
13.3.5. South Asia
13.3.6. Oceania
13.3.7. Middle East and Africa (Middle East and Africa)
13.4. Market Attractiveness Analysis By Region
14. North America Market Analysis 2019-2023 and Forecast 2024-2033
14.1. Introduction
14.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
14.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
14.3.1. By Country
14.3.1.1. U.S.
14.3.1.2. Canada
14.3.2. By Product
14.3.3. By Dosage Form
14.3.4. By Distribution Channels
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Product
14.4.3. By Dosage Form
14.4.4. By Distribution Channels
14.5. Market Trends
14.6. Drivers and Restraints - Impact Analysis
14.7. Key Players - Intensity Mapping
14.8. Country Level Analysis & Forecast
14.8.1. U.S. Market Analysis
14.8.1.1. Introduction
14.8.1.2. Market Analysis and Forecast by Market Taxonomy
14.8.1.2.1. By Product
14.8.1.2.2. By Dosage Form
14.8.1.2.3. By Distribution Channels
14.8.2. Canada Market Analysis
14.8.2.1. Introduction
14.8.2.2. Market Analysis and Forecast by Market Taxonomy
14.8.2.2.1. By Product
14.8.2.2.2. By Dosage Form
14.8.2.2.3. By Distribution Channels
15. Latin America Market Analysis 2019-2023 and Forecast 2024-2033
15.1. Introduction
15.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
15.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
15.3.1. By Country
15.3.1.1. Mexico
15.3.1.2. Brazil
15.3.1.3. Argentina
15.3.1.4. Rest of Latin America
15.3.2. By Product
15.3.3. By Dosage Form
15.3.4. By Distribution Channels
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Product
15.4.3. By Dosage Form
15.4.4. By Distribution Channels
15.5. Market Trends
15.6. Drivers and Restraints - Impact Analysis
15.7. Key Players - Intensity Mapping
15.8. Country Level Analysis & Forecast
15.8.1. Mexico Market Analysis
15.8.1.1. Introduction
15.8.1.2. Market Analysis and Forecast by Market Taxonomy
15.8.1.2.1. By Product
15.8.1.2.2. By Dosage Form
15.8.1.2.3. By Distribution Channels
15.8.2. Brazil Market Analysis
15.8.2.1. Introduction
15.8.2.2. Market Analysis and Forecast by Market Taxonomy
15.8.2.2.1. By Product
15.8.2.2.2. By Dosage Form
15.8.2.2.3. By Distribution Channels
15.8.3. Argentina Market Analysis
15.8.3.1. Introduction
15.8.3.2. Market Analysis and Forecast by Market Taxonomy
15.8.3.2.1. By Product
15.8.3.2.2. By Dosage Form
15.8.3.2.3. By Distribution Channels
16. Europe Market Analysis 2019-2023 and Forecast 2024-2033
16.1. Introduction
16.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
16.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
16.3.1. By Country
16.3.1.1. Germany
16.3.1.2. Italy
16.3.1.3. France
16.3.1.4. U.K.
16.3.1.5. Spain
16.3.1.6. BENELUX
16.3.1.7. Russia
16.3.1.8. Rest of Europe
16.3.2. By Product
16.3.3. By Dosage Form
16.3.4. By Distribution Channels
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Product
16.4.3. By Dosage Form
16.4.4. By Distribution Channels
16.5. Market Trends
16.6. Drivers and Restraints - Impact Analysis
16.7. Key Players - Intensity Mapping
16.8. Country Level Analysis & Forecast
16.8.1. Germany Market Analysis
16.8.1.1. Introduction
16.8.1.2. Market Analysis and Forecast by Market Taxonomy
16.8.1.2.1. By Product
16.8.1.2.2. By Dosage Form
16.8.1.2.3. By Distribution Channels
16.8.2. Italy Market Analysis
16.8.2.1. Introduction
16.8.2.2. Market Analysis and Forecast by Market Taxonomy
16.8.2.2.1. By Product
16.8.2.2.2. By Dosage Form
16.8.2.2.3. By Distribution Channels
16.8.3. France Market Analysis
16.8.3.1. Introduction
16.8.3.2. Market Analysis and Forecast by Market Taxonomy
16.8.3.2.1. By Product
16.8.3.2.2. By Dosage Form
16.8.3.2.3. By Distribution Channels
16.8.4. U.K. Market Analysis
16.8.4.1. Introduction
16.8.4.2. Market Analysis and Forecast by Market Taxonomy
16.8.4.2.1. By Product
16.8.4.2.2. By Dosage Form
16.8.4.2.3. By Distribution Channels
16.8.5. Spain Market Analysis
16.8.5.1. Introduction
16.8.5.2. Market Analysis and Forecast by Market Taxonomy
16.8.5.2.1. By Product
16.8.5.2.2. By Dosage Form
16.8.5.2.3. By Distribution Channels
16.8.6. BENELUX Market Analysis
16.8.6.1. Introduction
16.8.6.2. Market Analysis and Forecast by Market Taxonomy
16.8.6.2.1. By Product
16.8.6.2.2. By Dosage Form
16.8.6.2.3. By Distribution Channels
16.8.7. Russia Market Analysis
16.8.7.1. Introduction
16.8.7.2. Market Analysis and Forecast by Market Taxonomy
16.8.7.2.1. By Product
16.8.7.2.2. By Dosage Form
16.8.7.2.3. By Distribution Channels
17. East Asia Market Analysis 2019-2023 and Forecast 2024-2033
17.1. Introduction
17.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
17.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
17.3.1. By Country
17.3.1.1. China
17.3.1.2. Japan
17.3.1.3. South Korea
17.3.2. By Product
17.3.3. By Dosage Form
17.3.4. By Distribution Channels
17.4. Market Attractiveness Analysis
17.4.1. By Country
17.4.2. By Product
17.4.3. By Dosage Form
17.4.4. By Distribution Channels
17.5. Market Trends
17.6. Drivers and Restraints - Impact Analysis
17.7. Key Players - Intensity Mapping
17.8. Country Level Analysis & Forecast
17.8.1. China Market Analysis
17.8.1.1. Introduction
17.8.1.2. Market Analysis and Forecast by Market Taxonomy
17.8.1.2.1. By Product
17.8.1.2.2. By Dosage Form
17.8.1.2.3. By Distribution Channels
17.8.2. Japan Market Analysis
17.8.2.1. Introduction
17.8.2.2. Market Analysis and Forecast by Market Taxonomy
17.8.2.2.1. By Product
17.8.2.2.2. By Dosage Form
17.8.2.2.3. By Distribution Channels
17.8.3. South Korea Market Analysis
17.8.3.1. Introduction
17.8.3.2. Market Analysis and Forecast by Market Taxonomy
17.8.3.2.1. By Product
17.8.3.2.2. By Dosage Form
17.8.3.2.3. By Distribution Channels
18. South Asia Market Analysis 2019-2023 and Forecast 2024-2033
18.1. Introduction
18.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
18.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
18.3.1. By Country
18.3.1.1. India
18.3.1.2. Indonesia
18.3.1.3. Malaysia
18.3.1.4. Thailand
18.3.1.5. Rest of South Asia
18.3.2. By Product
18.3.3. By Dosage Form
18.3.4. By Distribution Channels
18.4. Market Attractiveness Analysis
18.4.1. By Country
18.4.2. By Product
18.4.3. By Dosage Form
18.4.4. By Distribution Channels
18.5. Market Trends
18.6. Drivers and Restraints - Impact Analysis
18.7. Key Players - Intensity Mapping
18.8. Country Level Analysis & Forecast
18.8.1. India Market Analysis
18.8.1.1. Introduction
18.8.1.2. Market Analysis and Forecast by Market Taxonomy
18.8.1.2.1. By Product
18.8.1.2.2. By Dosage Form
18.8.1.2.3. By Distribution Channels
18.8.2. Indonesia Market Analysis
18.8.2.1. Introduction
18.8.2.2. Market Analysis and Forecast by Market Taxonomy
18.8.2.2.1. By Product
18.8.2.2.2. By Dosage Form
18.8.2.2.3. By Distribution Channels
18.8.3. Malaysia Market Analysis
18.8.3.1. Introduction
18.8.3.2. Market Analysis and Forecast by Market Taxonomy
18.8.3.2.1. By Product
18.8.3.2.2. By Dosage Form
18.8.3.2.3. By Distribution Channels
18.8.4. Thailand Market Analysis
18.8.4.1. Introduction
18.8.4.2. Market Analysis and Forecast by Market Taxonomy
18.8.4.2.1. By Product
18.8.4.2.2. By Dosage Form
18.8.4.2.3. By Distribution Channels
19. Oceania Market 2019-2023 and Forecast 2024-2033
19.1. Introduction
19.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
19.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
19.3.1. By Country
19.3.1.1. Australia
19.3.1.2. New Zealand
19.3.2. By Product
19.3.3. By Dosage Form
19.3.4. By Distribution Channels
19.4. Market Attractiveness Analysis
19.4.1. By Country
19.4.2. By Product
19.4.3. By Dosage Form
19.4.4. By Distribution Channels
19.5. Market Trends
19.6. Drivers and Restraints - Impact Analysis
19.7. Key Players - Intensity Mapping
19.8. Country Level Analysis & Forecast
19.8.1. Australia Market Analysis
19.8.1.1. Introduction
19.8.1.2. Market Analysis and Forecast by Market Taxonomy
19.8.1.2.1. By Product
19.8.1.2.2. By Dosage Form
19.8.1.2.3. By Distribution Channels
19.8.2. New Zealand Market Analysis
19.8.2.1. Introduction
19.8.2.2. Market Analysis and Forecast by Market Taxonomy
19.8.2.2.1. By Product
19.8.2.2.2. By Dosage Form
19.8.2.2.3. By Distribution Channels
20. Middle East and Africa Market Analysis 2019-2023 and Forecast 2024-2033
20.1. Introduction
20.2. Historical Market Size (US$ Bn) Trend and Volume (Units) Analysis By Market Taxonomy, 2019-2023
20.3. Current and Future Market Value (US$ Bn) and Volume (Units) Analysis and Forecast, 2024-2033
20.3.1. By Country
20.3.1.1. GCC Countries
20.3.1.2. Türkiye
20.3.1.3. North Africa
20.3.1.4. South Africa
20.3.1.5. Rest of Middle East and Africa
20.3.2. By Product
20.3.3. By Dosage Form
20.3.4. By Distribution Channels
20.4. Market Attractiveness Analysis
20.4.1. By Country
20.4.2. By Product
20.4.3. By Dosage Form
20.4.4. By Distribution Channels
20.5. Market Trends
20.6. Drivers and Restraints - Impact Analysis
20.7. Key Players - Intensity Mapping
20.8. Country Level Analysis & Forecast
20.8.1. GCC Countries Market Analysis
20.8.1.1. Introduction
20.8.1.2. Market Analysis and Forecast by Market Taxonomy
20.8.1.2.1. By Product
20.8.1.2.2. By Dosage Form
20.8.1.2.3. By Distribution Channels
20.8.2. Türkiye Market Analysis
20.8.2.1. Introduction
20.8.2.2. Market Analysis and Forecast by Market Taxonomy
20.8.2.2.1. By Product
20.8.2.2.2. By Dosage Form
20.8.2.2.3. By Distribution Channels
20.8.3. South Africa Market Analysis
20.8.3.1. Introduction
20.8.3.2. Market Analysis and Forecast by Market Taxonomy
20.8.3.2.1. By Product
20.8.3.2.2. By Dosage Form
20.8.3.2.3. By Distribution Channels
20.8.4. North Africa Market Analysis
20.8.4.1. Introduction
20.8.4.2. Market Analysis and Forecast by Market Taxonomy
20.8.4.2.1. By Product
20.8.4.2.2. By Dosage Form
20.8.4.2.3. By Distribution Channels
21. Market Structure Analysis
21.1. Market Analysis by Tier of Companies
21.2. Market Share Analysis of Top Players
21.3. Market Presence Analysis
22. Competition Analysis
22.1. Competition Dashboard
22.2. Competition Benchmarking
22.3. Competition Deep Dive
22.3.1. Sanofi Pasteur Inc.
22.3.1.1. Overview
22.3.1.2. Product Portfolio
22.3.1.3. Sales Footprint
22.3.1.4. Key Financials
22.3.1.5. SWOT Analysis
22.3.1.6. Strategy Overview
22.3.2. Astrazeneca
22.3.2.1. Overview
22.3.2.2. Product Portfolio
22.3.2.3. Sales Footprint
22.3.2.4. Key Financials
22.3.2.5. SWOT Analysis
22.3.2.6. Strategy Overview
22.3.3. Csl Ltd.
22.3.3.1. Overview
22.3.3.2. Product Portfolio
22.3.3.3. Sales Footprint
22.3.3.4. Key Financials
22.3.3.5. SWOT Analysis
22.3.3.6. Strategy Overview
22.3.4. Abbbott
22.3.4.1. Overview
22.3.4.2. Product Portfolio
22.3.4.3. Sales Footprint
22.3.4.4. Key Financials
22.3.4.5. SWOT Analysis
22.3.4.6. Strategy Overview
22.3.5. Glaxosmithkline Plc.
22.3.5.1. Overview
22.3.5.2. Product Portfolio
22.3.5.3. Sales Footprint
22.3.5.4. Key Financials
22.3.5.5. SWOT Analysis
22.3.5.6. Strategy Overview
22.3.6. Serum Institute of India Pvt.Ltd
22.3.6.1. Overview
22.3.6.2. Product Portfolio
22.3.6.3. Sales Footprint
22.3.6.4. Key Financials
22.3.6.5. SWOT Analysis
22.3.6.6. Strategy Overview
23. Assumptions and Acronyms Used
24. Research Methodology